
Latest news, updates, and announcements from Iambic Therapeutics.

Iambic Therapeutics, an AI drug discovery company, secured over $100M in new funding following encouraging Phase 1/1b clinical data for its lead AI-discovered cancer drug, IAM1363. This HER2 inhibitor...

Iambic Therapeutics has successfully raised over $100 million to push its AI-discovered cancer drug, IAM1363, into expanded clinical trials. This pivotal moment moves AI from theoretical compound iden...

Iambic Therapeutics just raised $100M to advance its pipeline of AI-discovered cancer drugs, validating a transformative new model for drug discovery. The funding is driven by clinical success, includ...